0 item $0.00

Researching potential new treatments for obesity

The SYNCHRONIZE™-1 Trial is testing an investigational medication to see if it works to reduce body weight and whether it is safe and how the body handles taking it.

Who can participate?

You, or someone you know, may be able to take part if you/they:

  • are 18 years of age or older
  • have a BMI ≥ 30 kg/m2 (calculate your BMI)
  • OR
  • have a BMI ≥ 27.0 kg/m2 to 29.9 kg/m2 and a weight-related condition such as:
    • high blood pressure
    • high cholesterol
    • obstructive sleep apnea
    • problems with your heart or blood vessels
    • a liver condition involving build-up of fats (called “NASH”).
  • have made at least 1 attempt to lose weight through nutrition and physical activity, but did not meet
    your/their goal.

There are additional requirements to be able to take part. This study is being run in Victoria (Prahran).

Apply to participate in this study

 

If you are interested in participating or would like further information, please contact the SYNCHRONIZE™-1 Trial team:

Prasad Senevirathna
Clinical Research Coordinator
T: (03) 8532 1305
E: prasad.senevirathna@baker.edu.au